A joint venture of Hitachi’s Central Research Laboratory and Schools of Engineering and Medicine, University of Tokyo, led to the development of Contrast Agent Technology for ultra-sonic diagnostic equipment. The technology works by transforming the contrast agents made of nano-sized droplets into micron-sized bubbles that emit reflected signals requisite to get tumor tissue images. With this technology, we can get the information on blood vessels as well as tumor issues.
Mansoor Amiji at Northeastern University and MIT’s Robert Langer have developed a new nano-sized drug capsule to shrivel the Ovarian Cancer Tumors. It could be a great achievement as the ovarian cancer is quite difficult to treat and the survival chances are too less. The research was carried out by injecting the mice (with ovarian cancer) with pH-sensitive nanoparticle with paclitaxel (a cancer drug). The success of the research is mentioned in the journal Cancer Chemotherapy and Pharmacology. The new drug efficiently kills the ovarian cancer cells. I think the novel drug will be soon made public to ease the patients suffering from ovarian cancer.
Engineers at Purdue University in West Lafayette, Indiana are working to develop a grain-sized wireless device that the doctors can implant in the tumors to notify them with the exact dose of radiation and the location of the tumor. The wireless device dubbed as the “passive wireless transponder” is activated by placing electrical coils around the body to identify the precise location of the tumor. Well, the technology works just like the commercial microphones. The wireless device features a tiny version of the dosimeters. When the electrical foil is placed near the body, the signals are produced that sent the info from the dosimeter to a receiver.